Related references
Note: Only part of the references are listed.Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease
Frederic Sampedro et al.
NEUROBIOLOGY OF AGING (2021)
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
Lana M. Chahine et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases
Francisco P. M. Oliveira et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker
Rahul Gaurav et al.
MOVEMENT DISORDERS (2021)
Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease
Sohyun Jeong et al.
PLOS ONE (2021)
Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data
Jeong Won Lee et al.
PLOS ONE (2021)
Texture-based markers from structural imaging correlate with motor handicap in Parkinson's disease
Nacim Betrouni et al.
SCIENTIFIC REPORTS (2021)
Challenges in the diagnosis of Parkinson's disease
Eduardo Tolosa et al.
LANCET NEUROLOGY (2021)
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
Eleonora Fiorenzato et al.
MOVEMENT DISORDERS (2021)
Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes
Yun Jung Bae et al.
RADIOLOGY (2021)
Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis
Danny Bega et al.
NPJ PARKINSONS DISEASE (2021)
Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease
Lorena Jimenez-Sanchez et al.
NEUROPHARMACOLOGY (2020)
Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?
Nicolaas I. Bohnen et al.
LANCET NEUROLOGY (2020)
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni et al.
LANCET NEUROLOGY (2020)
Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni et al.
MOVEMENT DISORDERS (2020)
Sex differences in movement disorders
Sara Meoni et al.
NATURE REVIEWS NEUROLOGY (2020)
Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease
Rui Liu et al.
PARKINSONISM & RELATED DISORDERS (2020)
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort
Nicolas Nicastro et al.
BMC NEUROLOGY (2020)
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Autonomic failure in Parkinson's disease is associated with striatal dopamine deficiencies
Dagmar N. van Deursen et al.
JOURNAL OF NEUROLOGY (2020)
Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study
Giovanni Palermo et al.
MOVEMENT DISORDERS (2020)
Clinical and Imaging Progression in thePARSCohort:Long-TermFollow-up
Andrew Siderowf et al.
MOVEMENT DISORDERS (2020)
Patterns of striatal dopamine depletion in early Parkinson disease Prognostic relevance
Seok Jong Chung et al.
NEUROLOGY (2020)
Autonomic Testing Profiles in Scans without Evidence of Dopaminergic Deficit (SWEDD)
Lauren Jackson et al.
JOURNAL OF PARKINSONS DISEASE (2020)
123I-Ioflupane dopamine transporter imaging (DaTSCAN) appearances in relation to emotional responsiveness, impulsivity and olfaction in suspected Parkinsonian syndrome
Guglielmo La Torre et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes
Taro Shigekiyo et al.
SCIENTIFIC REPORTS (2020)
Minimal parkinsonism in the elderly is associated with striatal dopamine loss and pontine structural damage
Seok Jong Chung et al.
PARKINSONISM & RELATED DISORDERS (2020)
Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease
Jing Wang et al.
PARKINSONS DISEASE (2020)
The utility of the combined use of 123I-FP-CIT SPECT and neuromelanin MRI in differentiating Parkinson's disease from other parkinsonian syndromes
Eiji Matsusue et al.
ACTA RADIOLOGICA (2019)
Association of autonomic symptoms with presynaptic striatal dopamine depletion in drug-naive Parkinson's disease: An analysis of the PPMI data
Ryul Kim et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2019)
What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective
Stephane Thobois et al.
PARKINSONISM & RELATED DISORDERS (2019)
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease
Alan Whone et al.
BRAIN (2019)
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Ronald B. Postuma et al.
BRAIN (2019)
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease
Klaus Romero et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
Elina Makinen et al.
JOURNAL OF NEUROLOGY (2019)
Predicting cognitive decline with non-clinical markers in Parkinson's disease (PRECODE-2)
Tayyabah Yousaf et al.
JOURNAL OF NEUROLOGY (2019)
Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies
Abhishekh H. Ashok et al.
PSYCHOPHARMACOLOGY (2019)
Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system
Antonio Martin-Bastida et al.
BRAIN (2019)
Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease?
A. Okuzumi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Prediction of future weight change with dopamine transporter in patients with Parkinson's disease
Kyoungjune Pak et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Clinical implications of early caudate dysfunction in Parkinson's disease
Jacopo Pasquini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications
Ken Ikeda et al.
INTERNAL MEDICINE (2019)
Recent developments in drug-induced movement disorders: a mixed picture
Stewart A. Factor et al.
LANCET NEUROLOGY (2019)
No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson's disease
Emma A. Honkanen et al.
MOVEMENT DISORDERS (2019)
Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease
Gennaro Pagano et al.
MOVEMENT DISORDERS (2019)
Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's disease
Sven R. Suwijn et al.
EJNMMI RESEARCH (2019)
Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [123I]FP-CIT SPECT
Elina Jaakkola et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Yvette C. Wong et al.
MOVEMENT DISORDERS (2019)
The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis
Xiangming Wang et al.
NEUROLOGICAL SCIENCES (2019)
Molecular Imaging of the Dopamine Transporter
Giovanni Palermo et al.
CELLS (2019)
Neuroimaging in Vascular Parkinsonism
Karen K. Y. Ma et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)
Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease
Dareia S. Roos et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
The time delay between in vivo imaging and postmortem data poses a caveat on no link findings
Christian Pifl
MOVEMENT DISORDERS (2019)
Striatal DAT SPECT: Caveat Emptor!
Joel S. Perlmutter et al.
MOVEMENT DISORDERS (2019)
Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging
Rudolf A. Werner et al.
CLINICAL NUCLEAR MEDICINE (2019)
CSF β-amyloid42 and risk of freezing of gait in early Parkinson disease
Ryul Kim et al.
NEUROLOGY (2019)
Depressed caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease
Sang-Won Yoo et al.
NEUROBIOLOGY OF DISEASE (2019)
Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment
Heeyoung Kim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2019)
The role of molecular imaging in the frame of the revised dementia with Lewy body criteria (vol 7, pg 83, 2019)
Stelvio Sestini et al.
CLINICAL AND TRANSLATIONAL IMAGING (2019)
Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease
Han Soo Yoo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies
Gennaro Pagano et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease
Byoung Seok Ye et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction
Seok Jong Chung et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
C-11-PE2I and F-18-Dopa PET for Assessing Progression Rate in Parkinson's: A Longitudinal Study
Weihua Li et al.
MOVEMENT DISORDERS (2018)
The Cerebral Basis of Parkinsonian Tremor: A Network Perspective
Rick C. Helmich
MOVEMENT DISORDERS (2018)
Update on Molecular Imaging in Parkinson's Disease
Zhen-Yang Liu et al.
NEUROSCIENCE BULLETIN (2018)
Neuroimaging advances in Parkinson's disease
Vittorio Rispoli et al.
CURRENT OPINION IN NEUROLOGY (2018)
Can early dopamine transporter imaging serve as a predictor of Parkinson's disease progression and late motor complications?
Ruth Djaldetti et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease
Tayyabah Yousaf et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study
Ken Ikeda et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni et al.
MOVEMENT DISORDERS (2018)
Nigrostriatal dopamine transporter availability in early Parkinson's disease
Patrik Fazio et al.
MOVEMENT DISORDERS (2018)
Dopamine Reuptake Transporter-Single-Photon Emission Computed Tomography and Transcranial Sonography as Imaging Markers of Prediagnostic Parkinson's Disease
Alastair J. Noyce et al.
MOVEMENT DISORDERS (2018)
Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naive Parkinson's disease
Yasunori Mito et al.
PARKINSONISM & RELATED DISORDERS (2018)
Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off
Su Jin Chung et al.
PARKINSONISM & RELATED DISORDERS (2018)
Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease
Seok Jong Chung et al.
PARKINSONISM & RELATED DISORDERS (2018)
Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort
Ryul Kim et al.
PARKINSONISM & RELATED DISORDERS (2018)
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis
Matteo Bauckneht et al.
SLEEP MEDICINE REVIEWS (2018)
Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
Jared T. Hinkle et al.
PARKINSONISM & RELATED DISORDERS (2018)
Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease
H. Takahashi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
Eun Hye Jeong et al.
FRONTIERS IN NEUROLOGY (2018)
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis
Daniela J. Conrado et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Evaluation of Parkinson's disease by neuromelanin-sensitive magnetic resonance imaging and 123I-FP-CIT SPECT
Keita Kuya et al.
ACTA RADIOLOGICA (2018)
Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients
Carlo Rossi et al.
CLINICAL NEUROPHARMACOLOGY (2017)
Clinical utility of DaTscan imaging in the evaluation of patients with parkinsonism: a US perspective
Stuart H. Isaacson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Clinical utility of DaTscan imaging in the evaluation of patients with parkinsonism: a US perspective
Stuart H. Isaacson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease
E. Jaakkola et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification
Javier Blesa et al.
EXPERIMENTAL NEUROLOGY (2017)
Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients
Dorothee Kuebler et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Magnetic resonance imaging for the diagnosis of Parkinson's disease
Beatrice Heim et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies
Daryl J. Wile et al.
LANCET NEUROLOGY (2017)
Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation
Jeanne C. Latourelle et al.
LANCET NEUROLOGY (2017)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
Prediction of Cognitive Worsening in De Novo Parkinson's Disease: Clinical Use of Biomarkers
Dario Arnaldi et al.
MOVEMENT DISORDERS (2017)
Urinary Dysfunction in Early De Novo Patients With Parkinson's Disease
Gennaro Pagano et al.
MOVEMENT DISORDERS (2017)
Meta-Analysis of Dorsolateral Nigral Hyperintensity on Magnetic Resonance Imaging as a Marker for Parkinson's Disease
Philipp Mahlknecht et al.
MOVEMENT DISORDERS (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism
Elena A. Kozina et al.
NEUROBIOLOGY OF DISEASE (2017)
Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease
Maria Sierra et al.
NEUROLOGY (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease
Laura Saari et al.
NEUROLOGY (2017)
Survival in Parkinson's disease in relation to striatal dopamine transporter binding
Elina Makinen et al.
PARKINSONISM & RELATED DISORDERS (2017)
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease
Marina Picillo et al.
PARKINSONISM & RELATED DISORDERS (2017)
Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
Margherita Fabbri et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort
Danna Jennings et al.
JAMA NEUROLOGY (2017)
Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images
Arman Rahmim et al.
NEUROIMAGE-CLINICAL (2017)
Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
Silvia Paola Caminiti et al.
NEUROIMAGE-CLINICAL (2017)
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
Joachim Brumberg et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
Usman Saeed et al.
TRANSLATIONAL NEURODEGENERATION (2017)
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
Moran Artzi et al.
PLOS ONE (2017)
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient
Jeffrey H. Kordower et al.
ANNALS OF NEUROLOGY (2017)
Longitudinal Decline of Striatal Subregional [18F]FP-CIT Uptake in Parkinson's Disease
Changhwan Sung et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies
Valtteri Kaasinen et al.
ANNALS OF NEUROLOGY (2017)
Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?
Miguel Rosa-Grilo et al.
NPJ PARKINSONS DISEASE (2017)
Dopamine Transporter Imaging Deficit Predicts Early Transition to Synucleinopathy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Alex Iranzo et al.
ANNALS OF NEUROLOGY (2017)
Neuroimaging in Parkinson's disease: focus on substantia nigra and nigro-striatal projection
Daniela Frosini et al.
CURRENT OPINION IN NEUROLOGY (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?
M. A. Qamar et al.
NPJ PARKINSONS DISEASE (2017)
Dopamine transporter scanning in the evaluation of patients with suspected Parkinsonism: a case-based user's guide
Federico Rodriguez-Porcel et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Predictors of normal and abnormal outcome in clinical brain dopamine transporter imaging
Elina Jaakkola et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies
Roberto Erro et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease
Alberto Bergareche et al.
MOVEMENT DISORDERS (2016)
Neuroleptic-induced Parkinsonism: Clinicopathological study
Umar A. Shuaib et al.
MOVEMENT DISORDERS (2016)
Dopamine transporter scanning in the evaluation of patients with suspected Parkinsonism: a case-based user's guide
Federico Rodriguez-Porcel et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Molecular imaging of dopamine transporters
David J. Brooks
AGEING RESEARCH REVIEWS (2016)
Loss of Dorsolateral Nigral Hyperintensity on 3.0 Tesla Susceptibility-Weighted Imaging in Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Roberto De Marzi et al.
ANNALS OF NEUROLOGY (2016)
Cognition in Patients With a Clinical Diagnosis of Parkinson Disease and Scans Without Evidence of Dopaminergic Deficit (SWEDD): 2-Year Follow-Up
Kathryn A. Wyman-Chick et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2016)
[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies
J. J. van der Zande et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
The Contursi Family 20 Years Later: Intrafamilial Phenotypic Variability of the SNCA p.A53T Mutation
Lucia Ricciardi et al.
MOVEMENT DISORDERS (2016)
Novel movement disorder society-Parkinson's disease criteria: What about SWEDD and genetic forms?
Roberto Erro et al.
MOVEMENT DISORDERS (2016)
Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism
Stuart Taylor et al.
MOVEMENT DISORDERS (2016)
Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I-FP-CIT SPECT
Yun Jung Bae et al.
MOVEMENT DISORDERS (2016)
Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease
Jae Jung Lee et al.
NEUROBIOLOGY OF AGING (2016)
Serotonin-to-dopamine transporter ratios in Parkinson disease Relevance for dyskinesias
Andreas-Antonios Roussakis et al.
NEUROLOGY (2016)
Accuracy of clinical diagnosis of Parkinson disease A systematic review and meta-analysis
Giovanni Rizzo et al.
NEUROLOGY (2016)
Correlation between neuromelanin-sensitive MR imaging and 123I-FP-CIT SPECT in patients with parkinsonism
Keita Kuya et al.
NEURORADIOLOGY (2016)
Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease
Su Jin Chung et al.
PARKINSONISM & RELATED DISORDERS (2016)
Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
Jong-Min Kim et al.
PARKINSONISM & RELATED DISORDERS (2016)
Scan without evidence of dopaminergic deficit: A 10-year retrospective study
Nicolas Nicastro et al.
PARKINSONISM & RELATED DISORDERS (2016)
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease
Marcello Moccia et al.
SLEEP (2016)
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Ioannis U. Isaias et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function
Yoon-Sang Oh et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Retrograde Axonal Degeneration in Parkinson Disease
Patricia Tagliaferro et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
Arman Rahmim et al.
NEUROIMAGE-CLINICAL (2016)
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease
Marcello Moccia et al.
SLEEP (2016)
Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging
Jin Yong Hong et al.
PLOS ONE (2016)
Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease
Su Jin Chung et al.
PLOS ONE (2016)
Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
Valtteri Kaasinen
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study
M. T. Pellecchia et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease
Zahi Qamhawi et al.
BRAIN (2015)
Quantitative Analysis of 18F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4′-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease
Patrik Fazio et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Nigral anatomy and striatal denervation in genetic Parkinsonism: A family report
Roberto Ceravolo et al.
MOVEMENT DISORDERS (2015)
Nonmotor Symptoms in Subjects Without Evidence of Dopaminergic Deficits
Fabienne S. Sprenger et al.
MOVEMENT DISORDERS (2015)
Hyposmia in SWEDD
Laura Silveira-Moriyama et al.
MOVEMENT DISORDERS (2015)
Parkinsonism following neuroleptic exposure: A double-hit hypothesis?
Roberto Erro et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
Dario Arnaldi et al.
NEUROBIOLOGY OF AGING (2015)
Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease
Valtteri Kaasinen et al.
NEUROBIOLOGY OF AGING (2015)
Putaminal serotonergic innervation Monitoring dyskinesia risk in Parkinson disease
Jee-Young Lee et al.
NEUROLOGY (2015)
Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
Dolores Vilas et al.
PARKINSONISM & RELATED DISORDERS (2015)
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients
Gabriella Santangelo et al.
PARKINSONISM & RELATED DISORDERS (2015)
Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice
Fang Ba et al.
PARKINSONISM & RELATED DISORDERS (2015)
Progressive Dopamine Transporter Binding Loss in Autopsy-Confirmed Corticobasal Degeneration
Susanne Pirker et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies
Jenny McCleery et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson's Disease
Jae Jung Lee et al.
JOURNAL OF MOVEMENT DISORDERS (2015)
Baseline [123I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease
T. Nissen et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Neuroimaging Biomarkers for Parkinson Disease: Facts and Fantasy
Joel S. Perlmutter et al.
ANNALS OF NEUROLOGY (2014)
Uneven age effects of [18F]FP-CIT binding in the striatum of Parkinson's disease
Chong S. Lee et al.
ANNALS OF NUCLEAR MEDICINE (2014)
Dopamine transporter availability in motor subtypes of de novo drug-naive Parkinson's disease
Marcello Moccia et al.
JOURNAL OF NEUROLOGY (2014)
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus
Chris Vriend et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Cognitive Executive Impairment and Dopaminergic Deficits in De Novo Parkinson's Disease
Francoise J. Siepel et al.
MOVEMENT DISORDERS (2014)
Patients With Scans Without Evidence of Dopaminergic Deficit: A Long-Term Follow-up Study
Amit Batla et al.
MOVEMENT DISORDERS (2014)
Correlation of Striatal Dopamine Transporter Imaging With Post Mortem Substantia Nigra Cell Counts
Julia Kraemmer et al.
MOVEMENT DISORDERS (2014)
Imaging prodromal Parkinson disease The Parkinson Associated Risk Syndrome Study
Danna Jennings et al.
NEUROLOGY (2014)
Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
Jin Yong Hong et al.
NEUROLOGY (2014)
Longitudinal follow-up of SWEDD subjects in the PRECEPT Study
Kenneth Marek et al.
NEUROLOGY (2014)
Low clinical diagnostic accuracy of early vs advanced Parkinson disease Clinicopathologic study
Charles H. Adler et al.
NEUROLOGY (2014)
Differentiating drug-induced parkinsonism from Parkinson's disease: An update on non-motor symptoms and investigations
Francesco Brigo et al.
PARKINSONISM & RELATED DISORDERS (2014)
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study
Michele Tinazzi et al.
SCHIZOPHRENIA RESEARCH (2014)
Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study
Manuel Menedez-Gonzalez et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Correlation of Parkinson Disease Severity and 18F-DTBZ Positron Emission Tomography
Ing-Tsung Hsiao et al.
JAMA NEUROLOGY (2014)
Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications
M. Angela Cenci
FRONTIERS IN NEUROLOGY (2014)
Validation of Midbrain Positron Emission Tomography Measures for Nigrostriatal Neurons in Macaques
Christopher A. Brown et al.
ANNALS OF NEUROLOGY (2013)
Validation of nigrostriatal positron emission tomography measures: Critical limits
Morvarid Karimi et al.
ANNALS OF NEUROLOGY (2013)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction
R. Ceravolo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
European multicentre database of healthy controls for [I-123]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis
Andrea Varrone et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Impact of subcortical white matter lesions on dopamine transporter SPECT
Elisabeth Funke et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease
Sonia Benitez-Rivero et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
Nin Bajaj et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update
Klaus Tatsch et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
Alex Iranzo et al.
LANCET NEUROLOGY (2013)
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
Maria Sierra et al.
NEUROLOGY (2013)
Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: A SPECT follow-up study
Roberto Ceravolo et al.
PARKINSONISM & RELATED DISORDERS (2013)
Genetics of Parkinson's disease – state of the art, 2013
Vincenzo Bonifati
PARKINSONISM & RELATED DISORDERS (2013)
No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [I-123]FP-CIT (DaTSCAN) and SPECT
Gerda Thomsen et al.
EJNMMI RESEARCH (2013)
Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias
Sean J. Colloby et al.
BRAIN (2012)
Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease
Christoph Scherfler et al.
BRAIN (2012)
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment
Thuy C. Vu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Low nigrostriatal reserve for motor parkinsonism in nonhuman primates
Samer D. Tabbal et al.
EXPERIMENTAL NEUROLOGY (2012)
Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults
Ka Kit Wong et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT
Shirlony Morgan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0
David S. W. Djang et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
Nicolaas I. Bohnen et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Neuropathology of Sporadic Parkinson's Disease: Evaluation and Changes of Concepts
Kurt A. Jellinger
MOVEMENT DISORDERS (2012)
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease
Bernard Ravina et al.
MOVEMENT DISORDERS (2012)
The relationship between cerebral vascular disease and parkinsonism: The VADO study
A. Antonini et al.
PARKINSONISM & RELATED DISORDERS (2012)
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism
Michele Tinazzi et al.
SCHIZOPHRENIA RESEARCH (2012)
Age-Specific Progression of Nigrostriatal Dysfunction in Parkinson's Disease
Raul de la Fuente-Fernandez et al.
ANNALS OF NEUROLOGY (2011)
The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases
Friederike Sixel-Doering et al.
JOURNAL OF NEUROLOGY (2011)
Handedness and motor symptom asymmetry in Parkinson's disease
Matthew J. Barrett et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Increased dopamine transporter density in Parkinson's disease patients with social anxiety disorder
Tais S. Moriyama et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease
Henk W. Berendse et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Alex Iranzo et al.
LANCET NEUROLOGY (2011)
Residual Striatal Dopaminergic Nerve Terminals in Very Long-Standing Parkinson's Disease: A Single Photon Emission Computed Tomography Imaging Study
Ruth Djaldetti et al.
MOVEMENT DISORDERS (2011)
High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain)
Maria Sierra et al.
MOVEMENT DISORDERS (2011)
Akinetic-Rigid and Tremor-Dominant Parkinson's Disease Patients Show Different Patterns of FP-CIT Single Photon Emission Computed Tomography
Carsten Eggers et al.
MOVEMENT DISORDERS (2011)
Estimation of further disease progression of Parkinson's disease by dopamin transporter scan vs clinical rating
Thomas Vogt et al.
PARKINSONISM & RELATED DISORDERS (2011)
Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
Roberto Cilia et al.
PLOS ONE (2011)
Relationship Between SLC6A3 Genotype and Striatal Dopamine Transporter Availability: A Meta-Analysis of Human Single Photon Emission Computed Tomography Studies
Anna Costa et al.
SYNAPSE (2011)
Single Photon Emission Computed Tomography Striatal Asymmetry Index May Predict Dopaminergic Responsiveness in Parkinson Disease
Donatella Contrafatto et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study
C. Rossi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder a prospective study (vol 9, pg 1070, 2010)
A. Iranzo et al.
LANCET NEUROLOGY (2010)
Differentiating Vascular Parkinsonism from Idiopathic Parkinson's Disease: A Systematic Review
Seema Kalra et al.
MOVEMENT DISORDERS (2010)
Cognitive-Nigrostriatal Relationships in De Novo, Drug-Naive Parkinson's Disease Patients: A [I-123]FP-CIT SPECT Study
Flavio Nobili et al.
MOVEMENT DISORDERS (2010)
Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling
Roberto Cilia et al.
NEUROBIOLOGY OF DISEASE (2010)
A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease
J. Deeb et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Dopamine Transporter PET in Normal Aging: Dopamine Transporter Decline and its Possible Role in Preservation of Motor Function
Andre R. Troiano et al.
SYNAPSE (2010)
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Alex Iranzo et al.
LANCET NEUROLOGY (2010)
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
R. Nandhagopal et al.
BRAIN (2009)
Diagnostic accuracy of I-123-FP-CIT SPECT in possible dementia with Lewy bodies
John T. O'Brien et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Monoamine transporter availability in Parkinson's disease patients with or without depression
Swen Hesse et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3
Elisabeth M. van de Giessen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Aging effects on the dopamine transporter expression and compensatory mechanisms
Ignacio Cruz-Muros et al.
NEUROBIOLOGY OF AGING (2009)
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias
A. R. Troiano et al.
NEUROLOGY (2009)
History of falls in Parkinson disease is associated with reduced cholinergic activity
N. I. Bohnen et al.
NEUROLOGY (2009)
Visualizing Vesicular Dopamine Dynamics in Parkinson's Disease
Raul de la Fuente-Fernandez et al.
SYNAPSE (2009)
Cost-Effectiveness of 123I-FP-CIT SPECT in the Differential Diagnosis of Essential Tremor and Parkinson's Disease in Italy
Angelo Antonini et al.
MOVEMENT DISORDERS (2008)
Predictive Value of Nigrostriatal Dysfunction in Isolated Tremor: A Clinical and SPECT Study
Roberto Ceravolo et al.
MOVEMENT DISORDERS (2008)
Fatigue in levodopa-naive subjects with Parkinson disease
G. Schifitto et al.
NEUROLOGY (2008)
Striatal dopamine transporter abnormalities in patients with essential tremor
Ioannis U. Isaias et al.
NUCLEAR MEDICINE COMMUNICATIONS (2008)
Dopamine transporter imaging with [123I]FP-CIT SPECT:: potential effects of drugs
Jan Booij et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of Dopaminergic deficit (SWEDDs)
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2007)
Dopamine transporter relation to dopamine turnover in Parkinson's disease:: A positron emission tomography study
Vesna Sossi et al.
ANNALS OF NEUROLOGY (2007)
Gender differences in Parkinson's disease
Charlotte A. Haaxma et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease
J. Spiegel et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages
Jian Wang et al.
JOURNAL OF NEUROLOGY (2007)
Positron emission tomography in premotor Parkinson's disease
A. Jon Stoessl
PARKINSONISM & RELATED DISORDERS (2007)
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging
Vicky L. Marshall et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
Sex differences in striatal dopamine release in healthy adults
Cynthia A. Munro et al.
BIOLOGICAL PSYCHIATRY (2006)
Age-related differences in levodopa dynamics in Parkinson's:: implications for motor complications
V Sossi et al.
BRAIN (2006)
The Parkinson's complex: Parkinsonism is just the tip of the iceberg
JW Langston
ANNALS OF NEUROLOGY (2006)
Motor score of the unified Parkinson disease rating scale as a good predictor of Lewy body-associated neuronal loss in the substantia Nigra
S Greffard et al.
ARCHIVES OF NEUROLOGY (2006)
Striatal dopamine transporter availability with [123I]β-CIT SPECT is unrelated to gender or menstrual cycle
SE Best et al.
PSYCHOPHARMACOLOGY (2005)
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
JR Adams et al.
BRAIN (2005)
Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT
SJ Colloby et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
[99mTc] TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
A Siderowf et al.
NEUROLOGY (2005)
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral doparninergic deficit in early Parkinson's disease with unilateral symptoms
L Filippi et al.
NUCLEAR MEDICINE COMMUNICATIONS (2005)
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity
R Hilker et al.
ARCHIVES OF NEUROLOGY (2005)
Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT
K Stiasny-Kolster et al.
BRAIN (2005)
Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes
AM Catafau et al.
MOVEMENT DISORDERS (2004)
A new model for separation between brain dopamine and serotonin transporters in 123I-β-CIT SPECT measurements:: normal values and sex and age dependence
E Ryding et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
MM Ponsen et al.
ANNALS OF NEUROLOGY (2004)
Lack of regional selectivity during the progression of Parkinson disease
CS Lee et al.
ARCHIVES OF NEUROLOGY (2004)
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
AL Whone et al.
ANNALS OF NEUROLOGY (2003)
Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism
GR Uhl
MOVEMENT DISORDERS (2003)
Decreased plasma membrane expression of striatal dopamine transporter in aging
MF Salvatore et al.
NEUROBIOLOGY OF AGING (2003)
[123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression
K Marek et al.
NEUROLOGY (2001)
Sex differences in [123I]β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers
JK Staley et al.
SYNAPSE (2001)
Striatal dopamine transporters and cognitive functioning in healthy men and women
LH Mozley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell
HW Berendse et al.
ANNALS OF NEUROLOGY (2001)
SPECT imaging of the dopamine transporter with [123I]-β-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction
R Sakakibara et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
Reproducibility and effect of levodopa on dopamine transporter function measurements:: A [18F]CFT PET study
E Nurmi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
[I-123]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication
J Lavalaye et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Share Paper
